UTI Testing Report That Helps Support Treatment Decisions

Enhanced PCR reporting with CLSI M100 guidelines to support clinical decision-making and antibiotic stewardship

counter-02-variant-02-image-1
> 10 million
 UTI office visits annually
counter-02-variant-02-image-2
Up to 30 %
empiric antibiotic prescriptions are inappropriate
                  Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC12224138/                                                                   Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC8225033/

This enhanced reporting is intended to supplement, not replace, routine laboratory reports and standard clinical protocols.
Healthcare providers should continue to follow established diagnostic and treatment guidelines.

Intelligent Reporting Solution

CLSI M100 guidelines tailored to detected pathogens
Support decision-making with clear, actionable information
Seamless integration with existing laboratory workflows

Phone:

CLIA #:

Director:

Patient Name:

MRN:

Accession:

Patient Number:

Birth:

Collection Date:

Provider:

Age:

Received Date:

Home Phone:

Gender:

Specimen Matrix:

Urine

Account:

Pathogen Detected
Example of Pathogen detected
Pathogen

E. coli

Relative Load

Low

Resistance Gene Detected
Example of Resistance Gene Detected
Resistance Gene

Sulfonamides

Trimethoprim

Macrobid Comment

Example of Drugs to Avoid
Drugs to Avoid

Sulfadiazine, Sulfamethizole, Sulfamethoxazole, Sulfasalazine. Sulfisoxazole

Primsol

The organism is carrying antibiotic resistance markers that
correlate with potential Macrobid (nitrofurantoin) resistance.

E. coli
Example of Antibiotics
Antibiotics

Ampicillin

Ampicillin-Sulbactam

Cefazolin

Ceftriaxone

Ciprofloxacin

Levofloxacin

Nitrofurantoin

Trimethoprim-sulfamethoxazole

Drug Class

Penicillin

Penicillin with beta-lactamase inhibitor

First-generation cephalosporin

Third-generation cephalosporin

Fluoroquinolone

Fluoroquinolone

Nitrofuran

Sulfonamide combination

Original Reported On:

Accession:

Patient:

Printed:

Lab Result for:

Page 1 of 4

How does this benefit you?

tab-list-image-01 Differentiate your PCR services
tab-list-image-02 Add clinical value without additional equipment
tab-list-image-03 Reduce diagnostic uncertainty in UTI management
Copy of Copy of Untitled Design (2)

Partner with Streamline Scientific to help shape the future of enhanced PCR reporting.

This enhanced reporting is intended to supplement, not replace, routine laboratory reports and standard clinical protocols. Healthcare providers should continue to follow established diagnostic and treatment guidelines.

Want to learn more?